NervGen Pharma Corp. Common stock (NGEN) vs Voyager Therapeutics, Inc. (VYGR)
A side-by-side comparison of NervGen Pharma Corp. Common stock and Voyager Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NGEN
NervGen Pharma Corp. Common stock
$1.81HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
VYGR
Voyager Therapeutics, Inc.
$2.46HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — NGEN vs VYGR
growth of $100 · dividends reinvested · last 1yNGEN -57.6% (-57.6%/yr)VYGR -43.1% (-43.1%/yr)VYGR compounded faster over this window
NGEN VYGR
NGEN vs VYGR: by the numbers
- •NGEN is the larger company ($149M vs $148M market cap).
- •Both run net losses; NGEN's is the smaller (0.00% vs -312.63% net margin).
Metrics side by side
Valuation
| Metric | NGEN | VYGR |
|---|---|---|
| P/S ratio | N/A | 4.31 |
| P/B ratio | 12.19 | 0.96 |
Profitability
| Metric | NGEN | VYGR |
|---|---|---|
| Gross margin | 0.00% | -227.62% |
| Operating margin | 0.00% | -326.56% |
| Net margin | 0.00% | -312.63% |
| ROE | -397.38% | -69.78% |
| ROIC | -223.90% | -64.72% |
Growth (annualized)
| Metric | NGEN | VYGR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -23.59% |
| Total return CAGR (5Y) | N/A | -0.08% |
Go deeper
Dig into the metrics
NervGen Pharma Corp. Common stock ROEVoyager Therapeutics ROENervGen Pharma Corp. Common stock operating marginVoyager Therapeutics operating marginNervGen Pharma Corp. Common stock revenue growthVoyager Therapeutics revenue growthNervGen Pharma Corp. Common stock free cash flowVoyager Therapeutics free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.